Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1081-1090

  Sakamoto, Junichi ^a   Hamashima, Hiroshi ^b   Suzuki, Harumi ^b   Ito, Katsuki ^c   Mai, Masayoshi ^d   Saji, Shigetoyo ^e   Fukushima, Masakazu ^f   Matsushita, Yasuyuki ^g   Nakazato, Hiroaki ^h  

^a KYOTO UNIVERSITY   (Japan)

^b AICHI PREFECTURAL UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e GIFU UNIVERSITY   (Japan)

^f TAIHO PHARMACEUTICAL CO LTD   (Japan)

^g DAIICHI SANKYO CO   (Japan)

^h Yokoyama Gastrointestinal Hospital   (Japan)

Author keywords

5 FU; Immunohistochemistry; Prospective study; Randomized trial; RTSMA2 monoclonal antibody; Thymidylate synthase

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PYRIMIDINE DERIVATIVE; THYMIDYLATE SYNTHASE; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CLINICAL TRIAL; COLON TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LYMPH NODE METASTASIS; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TIME; TUMOR CELL LINE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; EPITOPES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PYRIMIDINES; RANDOM ALLOCATION; THYMIDYLATE SYNTHASE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 1642472091     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1081     Document Type: Article

References (37)

1. Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S and Kim YS: Sialosyl-Tn: a novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66: 1960-1966, 1990. (Pubitemid 20385969)
2. x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53: 3632-3637, 1993.
3. a as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 75: 2051-2056, 1995.
4. b, X and Y blood group antigens in human colonic tumors and normal tissue and in human tumor derived cell lines. Cancer Res 46: 1553-1561, 1986.
5. Schroy PC III, Brown Shimer S, Kim K, Johnson KA, Murnane MJ, Yang S, O'Brien MJ, Carney WP and Kupchik HZ: Detection of p21 ras mutations in colorectal adenomas and carcinomas by enzyme-linked immunosorbent assay. Cancer 76: 201-209, 1995.
6. Span M, Moerkerk PT, De Goeij AF and Arends JW: A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients. Int J Cancer 69: 241-245, 1996. (Pubitemid 26233305)
7. Goh HS, Yao J and Smith DR: P53 point mutation and survival in colorectal cancer patients. Cancer Res 55: 5217-5221, 1995.
8. Danenberg PV: Thymidylate synthase: a target enzyme in cancer chemotherapy. Biochim Biophys Acta 473: 73-92, 1977.
9. Beck A, Etienne MC, Chradame S, Fischel JL, Formento P, Rene N and Milano G: A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumor sensitivity to fluorouracil. Eur J Cancer 10: 1408-1411, 1994.
10. Johnston PG, Drake JC, Trepel J and Allegra CJ: Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and resistant human cancer cell lines. Cancer Res 52: 4306-4312, 1992.
11. Berger SH, Jenh CH, Johnston LF and Berger FG: Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells. Mol Pharmacol 28: 461-467, 1985. (Pubitemid 16224251)
12. Chu E, Drake JC, Koeller DM, Zinn S, Jamis-Dow CA, Yeh GC and Allegra CJ: Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines. Mol Pharmacol 39: 136-143, 1991.
13. Clark JL, Berger SH, Mittelman A and Berger FG: Thymidylate synthase gene amplification in a colon tumor resistant to fluoropyrimidine chemotherapy. Cancer Treat Rep 71: 261-265, 1987. (Pubitemid 17051726)
14. Peters GJ, van der Wilt CL, van Groeningen CJ, Smid K, Meijer S and Pinedo HM: Thymidylate synthase inhibition after administration of fluorouracil with and without leucovorin in colon cancer patients: implication for treatment with fluorouracil. J Clin Oncol 12: 2035-2042, 1994. (Pubitemid 24356018)
15. Mulder NH, Timmer-Bosscha H, Meersma GJ and Verschueren RC: Thymidylate synthase levels in tumor biopsies from patients with colorectal cancer. Anticancer Res 14B: 2677-2680, 1994.
16. Leichman L, Lenz HJ, Leichman CG, Groshen S, Danenberg K, Baranda J, Spears CP, Boswell W, Silberman H, Ortega A, Stain S, Breart R and Danenberg P: Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. Eur J Cancer 31: 1306-1310, 1995.
17. Johnston PG, Liang CM, Henry S, Chabner BA and Allegra CJ: The production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 51: 6668-6676, 1991.
18. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA and Allegra CJ: The role of thymidylate synthase expression in prognosis and outcome to adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12: 2640-2647, 1994. (Pubitemid 24379651)
19. Lenz HJ, Kathleen DD, Leichman CG, Florentine B, Johnston PG, Groshen S, Zhou L, Xiong YP, Deneberg PV and Leichman LP: p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clin Cancer Res 4: 1227-1234, 1998. (Pubitemid 28213334)
20. Yamachika T, Nakanishi H, Inada K, Tsukamoto T, Kato T, Fukushima M, Inoue M and Tatematsu M: A new prognostic factor for colorectal carcinoma, thymidylate synthase and its therapeutic significance. Cancer 82: 70-77, 1998. (Pubitemid 28070481)
21. Johnston PG, Lenz HJ, Leichman CG, Danenberg KD, Allegra CJ, Danenberg PV and Leichman L: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1412, 1995.
22. Leichman L, Lenz HJ, Leichman CG, Groshen S, Danenberg KD, Baranda J, Spears CP, Boswell W, Silberman H, Ortega A, Stain S, Beart R and Danenberg P: Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. Eur J Cancer 718: 1306-1310, 1995.
23. Johnston PG, Liang CM, Henry S, Chabner BA and Allegra CJ: Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 51: 6668-6676, 1991.
24. Johnston PG, Drake JC, Trepel J and Allegra CJ: Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res 52: 4306-4312, 1992.
25. Okabe H, Tsujimoto H and Fukushima M: Preparation of the antibodies against recombinant human thymidylate synthase for the detection of its intratumoral levels and the application to sensitivity-study of 5-fluorouracil. Oncol Rep 4: 685-690, 1997. (Pubitemid 27286971)
26. Behan KA, Johnston PG and Allegra GJ: Epitope mapping of a series of human thymidylate synthase monoclonal antibodies. Cancer Res 58: 2606-2611, 1998. (Pubitemid 28275433)
27. Okabe H, Koizumi K, Tujimoto H and Fukushima M: Epitope analysis and utility of monoclonal antibodies to native and recombinant human thymidylate synthase. Int J Mol Med 5: 133-138, 2000.
28. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmaek N, Drake JC, Chanbner BA and Allegra CJ: The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12: 2640-2647, 1994. (Pubitemid 24379651)
29. Gehan EA: A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrika 52: 203-223, 1965.
30. Cox DR: Regression models and life-tables. JR Stat Soc Ser B 34: 187-220, 1972.
31. Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
32. Carlo A, Domizia D, Stefania C, Giovanna A, Gianni T, Chiara B, Rita L, Frank M and Alberto S: Immunohistochemical quantitation of thymidylate syntase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. J Clin Oncol 17: 1760-1770, 1999.
33. Cascinu S, Aschele C, Bami S, Debemardis D, Baldo C, Tunesi G, Catalano V, Staccioli MP, Brenna A, Muretto P and Catalano G: Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovolin-modulated bolus 5-fluorouracil. Clin Cancer Res 5: 1996-1999, 1999. (Pubitemid 29399249)
34. Gorlic R, Metzger R, Dannenberg KD, Salonga D, Miles JS, Longo GSA, Fu J, Banerjee D, Klimstra D, Jhanwar S, Dannenberg P, Kemeny N and Bertino JR: Higher levels of thymidylate syntase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J Clin Oncol 16: 1465-1469, 1998. (Pubitemid 28175767)
35. Nozue M, Koike N, Kawamoto T, Toko K, Shindou T, Orii K, Kondou T, Mun Y, Nithou M, Todoroki T and Fukao K: Dependence of the thymidylate synthase inhibition rate on the interval after the last administration of tegafur in sigmoid colon cancer patients. J Surg Oncol 52: 115-118, 1993. (Pubitemid 23061961)
36. Marsh S, Collie-Duguid ESR, Li T, Liu X and McLeod HL: Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations Genomics 58: 310-312, 1999. (Pubitemid 29300314)
37. Kawakami K, Omura K, Kanehira E and Watanabe Y: Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers. Anticancer Res 19: 3249-3252, 1999. (Pubitemid 30042617)